Celularity CELU
NASDAQ CELU
$1.60 +0.22 (+15.94%)
At close: Oct 2, 2026 · 4:00 PM EDT

Celularity (CELU) Cash & Current Investments (2018 - 2026)

Updated

Celularity (CELU) recorded Cash & Current Investments of $368,000 in Q1 2026, up 25.6% from $293,000 a year earlier but down 94.0% from the prior quarter.

Analysis

Celularity (CELU) Cash & Current Investments (2018 - 2026) Analysis & Trends

At the end of FY2025, Celularity reported Cash & Current Investments of $6.18 million, up 736.7% from FY2024.

  • Annual Cash & Current Investments has a five-year compound annual growth rate of -35.3% (FY2020 to FY2025).
  • Across earlier years, Cash & Current Investments came in at $738,000 in FY2024 (+225.1%), $227,000 in FY2023 (-98.4%), $13.97 million in FY2022 (-62.5%) and $37.24 million in FY2021 (-31.4%).
  • Quarterly Cash & Current Investments has ranged from $211.00 in Q2 2021 to $72.72 million in Q3 2021 over the past five years.
  • On a year-over-year basis, Cash & Current Investments rose in four of the last eight quarters, with growth averaging 105.2%.
  • Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 736.7% in Q4 2025, against a decline of 100.0% in Q2 2021 at the low end.
  • Per Business Quant, the preceding three quarters came in at $6.18 million (Q4 2025), $120,000 (Q3 2025) and $863,000 (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 Celularity 46.69 Mn 39.16 Mn 2.39 Mn 368,000.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 368,000.00
Dec 31, 2025 6.18 Mn
Sep 30, 2025 120,000.00
Jun 30, 2025 863,000.00
Mar 31, 2025 293,000.00
Dec 31, 2024 738,000.00
Sep 30, 2024 133,000.00
Jun 30, 2024 467,000.00
Mar 31, 2024 1.90 Mn
Dec 31, 2023 227,000.00
Sep 30, 2023 273,000.00
Jun 30, 2023 3.08 Mn
Mar 31, 2023 8.53 Mn
Dec 31, 2022 13.97 Mn
Sep 30, 2022 42.65 Mn
Jun 30, 2022 38.00 Mn
Mar 31, 2022 48.04 Mn
Dec 31, 2021 37.24 Mn
Sep 30, 2021 72.72 Mn
Jun 30, 2021 211.00
API Access

Celularity Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=CELU&period=max&api_key=YOUR_API_KEY